… plus salbutamol as needed, with a risk reduction similar to that observed in the overall
populations of the studies included in this meta-analysis. This suggests that inclusion of the study …

… present meta analysis was that with regard to the most common exacerbations, defined by
the need for oral corticosteroids, budesonide/formoterol … regimens, budesonide/formoterol or …

Objective: To compare the effectiveness of budesonide/formoterol using fixed dosing (BUD/FORM)
with inhaled corticosteroid (ICS) alone or alternative ICS and long-acting β 2 -agonist …

… as the intervention drug, compared with placebo or budesonide or formoterol; 4) outcome
measures: the ICS-related adverse effects analyzed in this meta-analysis were as follows: …

… However, the present meta-analysis included a relatively … However, the present meta-analysis
has several limitations. … on the results through subgroup analysis and meta-regression. …

… The mean daily inhaled glucocorticoid dose was compared between the budesonide–formoterol
group and the budesonide group in all four studies. The results of the meta-analysis …

… same indirect meta-analysis, all doses of budesonide/formoterol (… Because the aim of
this meta-analysis was to compare … budesonide/formoterol and fluticasone/salmeterol [Citation19]. …

… Meta-regression and sensitivity analyses were used to assess heterogeneity … /formoterol
fumarate) and open combinations at or over 24 and 52 weeks. Sensitivity analyses and meta-…

… and formoterol use. An updated version of this analysis including 32 additional studies of
formoterol that … In response, AstraZeneca conducted a meta-analysis of all eligible AstraZeneca-…

… of this meta-analysis was to evaluate the effectiveness of budesonide/formoterol in the …
In summary, the present meta-analysis provides a useful and comprehensive assessment of …